Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Axsome Therapeutics, Inc. (AXSM) had Return on Equity of -65.65% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$150.04M |
|
$-47.97M |
|
$13.45M |
|
$136.59M |
|
$186.76M |
|
$-36.71M |
|
$-12.22M |
|
$-48.93M |
|
$-48.93M |
|
$-47.97M |
|
$-47.97M |
|
$-47.97M |
|
$-47.97M |
|
$-36.71M |
|
$-34.15M |
|
49.44M |
|
49.44M |
|
$-0.97 |
|
$-0.97 |
|
| Balance Sheet Financials | |
$536.62M |
|
$0.67M |
|
$103.17M |
|
$639.78M |
|
$342.10M |
|
$121.33M |
|
$224.61M |
|
$566.71M |
|
$73.08M |
|
$17.30M |
|
$73.08M |
|
49.81M |
|
| Cash Flow Statement Financials | |
$-75.80M |
|
$-0.35M |
|
$63.81M |
|
$315.35M |
|
$303.02M |
|
$-12.34M |
|
$47.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
0.62 |
|
2.62 |
|
91.04% |
|
-24.47% |
|
-24.47% |
|
-- |
|
-32.61% |
|
-31.97% |
|
$-76.15M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.73 |
|
0.75 |
|
119.26 |
|
|
Return on Equity |
-65.65% |
-277.30% |
|
-7.50% |
|
-24.68% |
|
$1.47 |
|
$-1.54 |
|
$-1.53 |
|